Home › Chronic Lymphocytic Leukemia › Iowa › Des Moines
Chronic Lymphocytic Leukemia clinical trials in Des Moines, IA
8 studies for Chronic Lymphocytic Leukemia are looking for participants at sites in and around Des Moines (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
RecruitingPhase 3
- Iowa Methodist Medical Center, Des Moines
- UI Health Care Mission Cancer and Blood - Des Moines Clinic, Des Moines
- Broadlawns Medical Center, Des Moines
- and 5 more
A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
RecruitingPhase 2
- Mission Cancer + Blood, Waukee · 14 mi away
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
- Iowa Methodist Medical Center, Des Moines
- UI Health Care Mission Cancer and Blood - Des Moines Clinic, Des Moines
- Mercy Medical Center - Des Moines, Des Moines
- and 6 more
Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL
RecruitingPhase 3
- Iowa Methodist Medical Center, Des Moines
- UI Health Care Mission Cancer and Blood - Des Moines Clinic, Des Moines
- Broadlawns Medical Center, Des Moines
- and 5 more
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
RecruitingPhase 3
- Mission Cancer and Blood, Waukee · 14 mi away
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
RecruitingPhase 3
- University of Iowa Health Care. ( Site 0057), Waukee · 14 mi away
A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
RecruitingPhase 3
- Mission Cancer and Blood, Waukee · 14 mi away
A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)
RecruitingPhase 3
- University of Iowa Health Care /ID# 267206, Des Moines
Chronic Lymphocytic Leukemia trials in other cities
- Boston, MA31 studies
- Columbus, OH29 studies
- Durham, NC28 studies
- Washington, DC22 studies
- Seattle, WA22 studies
- Rochester, MN20 studies
- New York City, NY20 studies
- Houston, TX18 studies
- Baldwin Park, CA18 studies
- Cincinnati, OH15 studies
- Milwaukee, WI15 studies
- Chicago, IL14 studies
Other studies in Des Moines
- Non-Small Cell Lung Cancer10 studies
- Breast Cancer9 studies
- Lung Cancer9 studies
- Colorectal Cancer8 studies
- Overweight7 studies
- Obesity6 studies
- Multiple Myeloma6 studies
- Bladder Cancer6 studies
- Type 2 Diabetes5 studies
- Cardiovascular Disease5 studies
- Burkitt Lymphoma5 studies
- Prostate Cancer5 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.